YKL-40 represents a biomarker of systemic inflammation and high YKL-40 levels were found in numerous pathological conditions, such as atherosclerosis, diabetes, obstructive lung disease, asthma, liver fibrosis, inflammatory bowel disease, rheumatoid arthritis, and cancer [84]. Here, CHI3L1 is linked to inflammatory bowel disease.